期刊文献+

2型糖尿病合并非酒精性脂肪肝相关危险因素分析 被引量:3

Analysis of correlated risk factors of type 2 diabetes associated with nonalcoholic fatty liver
下载PDF
导出
摘要 目的:探讨影响2型糖尿病(T2DM)合并非酒精性脂肪肝(NAFL)的相关危险因素。方法:45例老年T2DM患者根据B超检查结果,分为T2DM合并NAFL组(A组,23例)与T2DM无脂肪肝组(B组,25例),对两组患者的身高、体重、收缩压(SBP)、舒张压(DBP)、空腹血糖(FPG)、餐后2h血糖(2hPG)、糖化血红蛋白(HbA1c)、三酰甘油(TG)、总胆固醇(TC)、低密度脂蛋白(LDL-C)、高密度脂蛋白(HDL-C)、APO-A1、APO-B等指标进行测定分析,行肝脏超声检查,计算血浆致动脉粥样硬化指数(AIP)、体重指数(BMI)、APO-A1/APO-B。结果:A组与B组比较,SBP、DBP、BMI、TG、AIP水平明显升高(P<0.05或P<0.01),APO-A1水平明显降低,两组FPG、2hPG、HDL-C、APO-B水平、APO-A1/APO-B值差异无显著性(P>0.05)。结论:2型糖尿病合并非酒精性脂肪肝与高血压、HbA1c升高、脂代谢紊乱及肥胖等有关。 Objective: To explore the correlated risk factors associated with type 2 diabetes complicated with nonalcoholic fatty liver. Methods: 48 patients with type 2 diabetes were divided into two groups according to whether the patients presented with fatty liver or not. Height and weight, SBP, DBP, FPG, 2 hPG, HbA1c, blood lipid (TG, TC, LDL-C, HDL-C,APO- A1, APO-B)level were measured and AIP, BMI, APO-A1/APO-B was calculated in 23 cases of type 2 diabetes patients complicated with nonalcoholic fatty liver(group A). 25 cases of type 2 diabetes patients without nonalcoholic fatty liver(group B) were taken as control.Results: SBP, DBP, HbA1c, BMI, triglycerides (TG) and AIP are higher but APO-A1 is lower in group A than that in group B (P〈0.05 or P〈0.01).There are not significant differences between A and B groups on FPG, 2 h PG, HDL-C, APO-B, APO-A1/APO-B (P〉0.05).Conclusion: Type 2 diabetes complicated with nonalcoholic fatty liver is related to dyslipidemia, high blood glucose and obesity.
出处 《中国医药导报》 CAS 2009年第17期23-24,共2页 China Medical Herald
  • 相关文献

参考文献10

  • 1杨生,岳桂英.2型糖尿病合并脂肪肝患者血清肿瘤坏死因子-α水平增高与胰岛素抵抗指数相关分析[J].世界华人消化杂志,2004,12(6):1485-1487. 被引量:13
  • 2James O,Day C.Nonalcoholic steatohepatitis:another diasease of affluence[J].Lancet,1999,353(9165):634-1636.1
  • 3Sheth SG,Cordon FD,Chopra S.Nonalcoholic steatohepatitis[J].Ann Intern Med,1997,126(2):137-145.
  • 4Fong DG,Nehra V,Lindor KD,et al,Metabolic and nutritional consideration in nonalcoholic fatty liver[J].Hepatology,2000,32(1):3-10.
  • 5Mareeau P,Biron S,Hould FS,et al.Liver pathology and metabolic syndrome X in severe obesity[J].J Clin Endoerinol Metab,1999,84(5):1513-1517.
  • 6Marehesini G,Brizi M,Morselli-Labate AM,et al.Association of nonalcoholic fatty liver disease with insulin resistance[J].Am J Med,1999,107(5):450-455.
  • 7Harper P,Wadstrom C,Backnum L,et al.Increased liver camitine content in obese women[J].Am J Clin Nutr,1995,61:18-25.
  • 8Jeffrey B,Schwmmer MD,Reena D,et al.Obesity,insulin resistance,and other elinieopathological correlates of pediatric nonalcoholic fatty liver disease[J].The Journal of Pediatrics,2003,10:500-505.
  • 9WANG LiDong1, ZHOU Qi1, WEI JunPing1, YANG WanCai1, ZHAO Xin1, WANG LiXia1, ZOU Jian Xiang1, GAO ShanShan1, LI YongXin1 and YANG C.S.2Keywords esophageal neoplasms,apoptosis,precancerous lesions,Waf1 p21 gene,p53.Apoptosis and its relationship with cell proliferation,p53,Waf1p21,bcl-2 and c-mycin esophageal carcinogenesis studied with a high-risk population in northern China[J].World Journal of Gastroenterology,1998,4(4):15-21. 被引量:300
  • 10Kelley DE,McKolanis TM,Hegazi RAF,et al.Fatty liver in type 2 diabetes mellitus:relation to regional adiposity,fatty acids,and insulin resistanee[J].Am J Physiol Endocrinol Metab,2003,285:906-916.

二级参考文献22

  • 1王玉敏.B型超声"明亮肝”100例实验室肝功能检验分析[J].世界华人消化杂志,2000,8(z1). 被引量:2
  • 2Lofgren P, Van Harmelen V, Reynisdottir S, Naslund E, Ryden M, Rossner S, Arner P. Secretion of tumor necrosis factor-a shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue. Diabetes 2000;49:688-692.
  • 3Marchesini G, Brizi M, Morselli labate AM. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999;107:450-455.
  • 4Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homestasis model assessment; insulin resistance and B-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985;28:412-419.
  • 5Cortez-Pinto H, Chatham J, Chacko CP, Arnold C, Rashid A,Diehl AM. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA 1999;282:1659-1664.
  • 6Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis.Ann intern Med 1997;126:137-145.
  • 7Sharabi Y, Eldad A. Nonalcoholic fatty liver disease is associated with hyperlipidemia and obesity. Am J Med 2000;109:171 -176.
  • 8James o, Day C. Nonalcoholic steatohepatitis: another disease of affluence. Lancet 1999;353:1634-1636.
  • 9Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G,Bugianesi E, McCullough-Arthur J, Forlani G, Mclchionda N.Associution of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999;107:450-455.
  • 10Harper P, Wadstrom C, Backman L, Cederblad G. Increased liver carnitine content in obese women. Am J Clin Nutr 1995;61:18-25.

共引文献311

同被引文献26

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部